Armistice Capital
$3.4B Assets Reported
455 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS INC | 5,916,000 | $200M | 5.9% |
| CYTK | CYTOKINETICS INC | 2,664,538 | $176M | 5.2% |
| PTCT | PTC THERAPEUTICS INC | 2,464,449 | $168M | 5.0% |
| TVTX | TRAVERE THERAPEUTICS INC | 4,897,417 | $146M | 4.3% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 264,583 | $139M | 4.1% |
| IMVT | IMMUNOVANT INC | 5,464,916 | $136M | 4.0% |
| SUPN | SUPERNUS PHARMACEUTICALS | 1,895,347 | $98M | 2.9% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 724,000 | $95M | 2.8% |
| FRPT | FRESHPET INC | 1,093,307 | $64M | 1.9% |
| INCY | INCYTE CORP | 656,817 | $62M | 1.8% |
Track Armistice Capital's 13F portfolio: $3.4B in reported holdings, 455 positions. Top holdings, AUM, and quarterly changes on SentiSense.